2007
DOI: 10.1016/j.ajo.2006.10.048
|View full text |Cite
|
Sign up to set email alerts
|

Successful Treatment of Resistant Ocular Fusariosis With Posaconazole (SCH-56592)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
63
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 88 publications
(63 citation statements)
references
References 21 publications
0
63
0
Order By: Relevance
“…However, its corneal penetration is poor and has not been effective for deeper keratitis. 5 In addition, some fungal pathogens such as Fusarium, which has been reported as a common pathogen, can penetrate an intact Descemet membrane, resulting in endophthalmitis. 6 Therefore, early diagnosis and treatment are important in the proper management of fungal keratitis.…”
Section: Introductionmentioning
confidence: 99%
“…However, its corneal penetration is poor and has not been effective for deeper keratitis. 5 In addition, some fungal pathogens such as Fusarium, which has been reported as a common pathogen, can penetrate an intact Descemet membrane, resulting in endophthalmitis. 6 Therefore, early diagnosis and treatment are important in the proper management of fungal keratitis.…”
Section: Introductionmentioning
confidence: 99%
“…Topical voriconazole is increasingly favored among ophthalmologists because of its wide spectrum of coverage against yeasts and filamentous agents of fungal keratitis [39]. Topical and oral posaconazole have also been used with success in therapy of Fusarium keratitis, resistant to voriconazole [40,41]. We should see for clinical signs of improvement like diminution of pain, disappearance of satellite lesions, rounding out of the feathery margins of the ulcer and hyperplastic masses or fibrous sheets in the region of healing fungal lesions [42].…”
Section: Treatment Of Fungal Keratitismentioning
confidence: 99%
“…Combination of systemic antifungal medications with topical treatment was suggested for immunocompromised patients with severe infections (60). Treatment with oral posaconazole has been reported to be successful in those patients not responsive to voriconazole therapy (61). As an early antifungal therapy is necessary for treatment, injection of amphotericin B or voriconazole is warranted for cases infected by mold endophthalmitis (51,62).…”
Section: Treatmentmentioning
confidence: 99%